FDA Approved: ENTYVIO — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved Entyvio (vedolizumab) in its original application for treatment of moderate-to-severe Crohn's disease and ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

ORIG AP for ENTYVIO (VEDOLIZUMAB)